CollPlant

CollPlant is an aesthetic medicine company that develops and commercializes tissue regeneration products for the medical sector. Read more

Yehiel Tal's photo - CEO of CollPlant

CEO

Yehiel Tal

CEO Approval Rating

68/100

Founded:

2004

Status:

PublicIndependent CompanyNYSECLPT

COLLPLANT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Akari is a top competitor of CollPlant. Akari was founded in London, England} in 2005. Akari competes in the Pharmaceuticals industry. Compared to CollPlant, Akari generates $12.7M less revenue.

Brainstorm Cell is CollPlant's #2 competitor. Brainstorm Cell is headquartered in New York, New York, and was founded in 2000. Brainstorm Cell competes in the Biotechnology field. Brainstorm Cell generates 7.28% the revenue of CollPlant.

Cell Cure has been one of CollPlant's top competitors. Cell Cure is a Private company that was founded in 2005 in Jerusalem, Center District. Like CollPlant, Cell Cure also competes in the Pharmaceuticals industry. Compared to CollPlant, Cell Cure has 8 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of CollPlant?

CollPlant Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$13.7M

CollPlant's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 4.7M. Over the last four quarters, CollPlant's revenue has grown by 62.6%. Specifically, in Q1 2021's revenue was $4M; in Q4 2020, it was $3.7M; in Q3 2020, it was $3.5M; in Q2 2020, CollPlant's revenue was $2.5M.

CollPlant Acquisitions

No recent acquisitions found related to CollPlant

CollPlant Funding History

Since CollPlant was founded in 2004, it has participated in 10 rounds of funding. In total CollPlant has raised $73.2M. CollPlant's last funding round was on Feb 2021 for a total of $35.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Feb 2021
$35M
-
Private Placement
Sep 2019
$5.5M
-
Private Placement
Nov 2017
$7.4M
-
Equity
Oct 2017
$2M
-
Equity
Sep 2017
$5M
-

Since CollPlant was founded in 2004, it has participated in 10 rounds of funding. In total CollPlant has raised $73.2M. CollPlant's last funding round was on Feb 2021 for a total of $35.0M

CollPlant Investments

No recent investments found related to CollPlant

CollPlant News

May 4, 2021Zacks

What's in the Cards?

CollPlant (CLGN) is set to report earnings and revenues, and provide product updates when it releases... See more »
March 29, 20213D Printing Industry

CollPlant gains $103M contract amid 165% FY 2020 revenue surge

Israeli bioprinting firm CollPlant has reported an annual revenue increase of 165% within its FY 2020... See more »
March 26, 2021BioSpace

CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial re... See more »
March 10, 2021Design News

3D Systems Expands Efforts in Bioprinting for Regenerative Medicine

Driven by progress in its collaboration with United Therapeutics in developing 3D printing systems fo... See more »
February 25, 2021BioSpace

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announ... See more »

CollPlant Press Releases

September 21, 2020LD Micro

CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant

Read this press release and other recent news about CollPlant Biotechnologies Ltd. (CLGN) at ldmicro.... See more »
February 4, 2020PR Newswire

CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments

REHOVOT, Israel, Feb. 4, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic ... See more »
October 28, 2019Network Newswire

CLGN) Starts Presentation at Dawson James Small Cap Growth Conference - NetworkNewsWire

CollPlant (NASDAQ: CLGN) is focused on 3D bioprinting of tissues and organs, and on developing and co... See more »
October 22, 2019PR Newswire

CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee

REHOVOT, Israel, Oct. 22, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine comp... See more »
June 4, 2019PR Newswire

Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

REHOVOT, Israel, June 4, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine compa... See more »
March 18, 2019PR Newswire

CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix STR With Arthrex a World Leader in Orthopedics

NESS ZIONA, Israel, March 18, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine ... See more »

CollPlant Videos

Social Media

CollPlant Headquarters

4 Oppenheimer Street P.O. Box 4132

Rehovot, Center District7670104

972-73-2325600

Driving Directions »

Trending Companies

CollPlant Summary

ABOUT

Overview

CollPlant is an aesthetic medicine company that develops and commercializes tissue regeneration products for the medical sector. CollPlant was founded in 2004. CollPlant's headquarters is located in Rehovot, Center District, IL 7670104. It has raised ...

CEO

CollPlant's CEO, Yehiel Tal, currently has an approval rating of 68%. CollPlant's primary competitors are Akari, Brainstorm Cell & Cell Cure.

Frequently Asked Questions about CollPlant

  1. When was CollPlant founded?

    CollPlant was founded in 2004
  2. Who is CollPlant's CEO?

    CollPlant's CEO is Yehiel Tal
  3. How much revenue does CollPlant generate?

    CollPlant generates $13.7M in revenue
  4. How much funding does CollPlant have?

    CollPlant has historically raised $73.3M in funding
  1. Where is CollPlant's headquarters?

    CollPlant's headquarters is in Rehovot Center District, IL
  2. How many employees does CollPlant have?

    CollPlant has 38 employees
  3. What sector does CollPlant operate in?

    CollPlant is in Pharmaceuticals, Biotechnology
  4. Who are CollPlant's competitors?

    CollPlant's top competitors are Akari, Brainstorm Cell, Cell Cure